McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
701.22
+4.24 (0.61%)
Sep 9, 2025, 12:31 PM - Market open
McKesson Employees
McKesson had 51,000 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
51,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$7,403,824
Profits / Employee
$62,039
Market Cap
87.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 51,000 | 0 | - |
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | 80,000 | 0 | - |
Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
Mar 31, 2018 | 78,000 | 0 | - |
Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
Mar 31, 2014 | 42,800 | -700 | -1.61% |
Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
Mar 31, 2010 | 32,500 | 0 | - |
Mar 31, 2009 | 32,500 | -400 | -1.22% |
Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
Mar 31, 2005 | 25,200 | 600 | 2.44% |
Mar 31, 2004 | 24,600 | 100 | 0.41% |
Mar 31, 2003 | 24,500 | 500 | 2.08% |
Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
Mar 31, 1998 | 13,700 | 400 | 3.01% |
Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
Mar 31, 1996 | 11,300 | -900 | -7.38% |
Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MCK News
- 4 weeks ago - McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Mckesson lifts annual profit forecast on robust demand for specialty drugs - Reuters
- 4 weeks ago - McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 5 weeks ago - McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share - Business Wire
- 6 weeks ago - McKesson Defied The Doubters (Including Me)--And Could Do It Again - Seeking Alpha
- 7 weeks ago - Our Top 10 High Growth Dividend Stocks - July 2025 - Seeking Alpha
- 2 months ago - McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Business Wire
- 2 months ago - McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date - Business Wire